Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicenter trial of Deferasirox in myelodysplastic syndrome with transfusional hemosiderosis
2006-006147-31Phase 3Completed
- Sponsor
- GIMEMA
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of deferasirox in myelodysplastic syndrome (MDS) and hemosiderosis, sponsored by GIMEMA. Primary endpoint: Primary - Safety and tolerability. Started May 2007; status: completed.
02
Drugs
deferasirox
03
Conditions
myelodysplastic syndrome (MDS)hemosiderosis
Beyond the preview
Go deeper on 2006-006147-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006147-31.